Trademarkia Logo

Australia

AU$
MELBRIXYN
Protected: Registered/protected

Last updated on 7 May 2024

Owner Info

Novartis AG

CH-4002 Basel

SWITZERLAND,

Serial Number

2411457 filed on 2 Oct 2023

Correspondent

Novartis Pharma AG, Trademark Department

Postfach,

CH-4002 Basel,

SWITZERLAND

MELBRIXYN

Classification Information


Class [005]
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; Read More

Mark Details


Serial Number

2411457

Registered On

2 Oct 2023

Renewal On

2 Oct 2033

Mark Type

WORD

Priority Claim (Convention Details)


Date

28 Sept 2023

Mark Type

CH

Legal History


Show more

Status DateAction Taken
7th May 2024International Registration in Australia Protected correspondence sent
6th May 2024IP Right Registration Published
6th May 2024Status change to Registered/Protected
29th Feb 2024Application Accepted correspondence sent
29th Feb 2024IP Right has been Examined
29th Feb 2024IP Right Acceptance Published
8th Dec 2023Status change to Accepted
8th Dec 2023Examination expedited
8th Dec 2023Awaiting examination
7th Dec 2023IP Right Filed Published